AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Five-year Outcome of Laparoscopic Gastric Sleeve

Recruitingn/aAges 18 Years - 65 YearsAllTartu University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The aim of this study is to evaluate the long-term (5-year follow-up) results of laparoscopic gastric sleeve (LGS) in terms of weight loss and obesity related comorbidities, as well as the risk factors associated with postoperative nutritional deficiencies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * The criteria for bariatric surgery: BMI of \>40, or \>35 with certain obesity related comorbidities Exclusion Criteria: * Patients who did not fill the inclusion criteria
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Tartu University Hospital
Tartu, Estonia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy